Does PEGFILGRASTIM Cause Mobility decreased? 141 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Mobility decreased have been filed in association with PEGFILGRASTIM (ZIEXTENZO). This represents 0.2% of all adverse event reports for PEGFILGRASTIM.
141
Reports of Mobility decreased with PEGFILGRASTIM
0.2%
of all PEGFILGRASTIM reports
3
Deaths
25
Hospitalizations
How Dangerous Is Mobility decreased From PEGFILGRASTIM?
Of the 141 reports, 3 (2.1%) resulted in death, 25 (17.7%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGFILGRASTIM. However, 141 reports have been filed with the FAERS database.
What Other Side Effects Does PEGFILGRASTIM Cause?
Device adhesion issue (11,326)
Wrong technique in product usage process (10,217)
Unintentional medical device removal (8,882)
Device malfunction (6,818)
Device use error (6,001)
Device issue (5,071)
Accidental exposure to product (4,967)
Device occlusion (3,239)
Off label use (3,228)
Bone pain (2,266)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which PEGFILGRASTIM Alternatives Have Lower Mobility decreased Risk?
PEGFILGRASTIM vs PEGFILGRASTIM-APGF
PEGFILGRASTIM vs PEGFILGRASTIM-BMEZ
PEGFILGRASTIM vs PEGFILGRASTIM-CBQV
PEGFILGRASTIM vs PEGFILGRASTIM-JMDB
PEGFILGRASTIM vs PEGINTERFERON ALFA